← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 29, 2020Last known activity
Feb 29, 2020
Timeline
2000s
- Jun 1, 2008
Aposcience AG— Founded
Drugs by trial phase (1 distinct, 1 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (2)
- NCT04277598Study directorPhase 1/Phase 2Feb 29, 2020
- NCT04277598Lead sponsorPhase 1/Phase 2Feb 29, 2020
Details
- Founded
- Vienna, AT Jun 1, 2008
- Last known activity
- Feb 29, 2020